The manufacturer Johnson & Johnson did not adequately warn doctors and patients that Risperdal can cause gynecomastia which is the development of female breasts in males. This condition is highly embarrassing for young boys who frequently are teased and bullied by other children for this condition. Many boys are fearful of being seen in school locker rooms and may avoid playing sports or engaging in other activities that might reveal this condition. Most of these boys are psychologically vulnerable because they have a diagnosis of emotional issues necessitated the Risperdal prescription to begin with. Risperdal is an antipsychotic drug.
Boys and young men with Gynecomastia may require a mastectomy which is surgical removal of the breasts. There is evidence that Johnson & Johnson concealed the risks of Gynecomastia in order to increase sales of Risperdal and to increase the company’s profits. The lawsuits blame the manufacturer for putting profits ahead of public safety.